Combining Daratumumab with VRd Improves Outcomes in Patients with Transplant-Ineligible or Transplant-Deferred Newly Diagnosed Multiple Myeloma By Ogkologos - March 3, 2025 528 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the CEPHEUS study Source RELATED ARTICLESMORE FROM AUTHOR Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides Protection Against HPV16 or HPV18 Infection and Is Not Inferior To Two Doses MOST POPULAR Breast Cancer Survivor Shares Inspiring Images Of Herself As “Bold Indian... March 1, 2019 Deaf Football Team Makes History, Heads To School’s First Finals Game... November 24, 2021 Early Signs of Efficacy of New Targeted Agents and Immunotherapies Reported... September 24, 2021 Liquid Biopsies for Cancer: What to Know and What to Expect November 3, 2022 Load more HOT NEWS ‘Normal’ cells and ‘cancer’s surprising circular DNA’: Inside Cancer Grand Challenges... Foodie Fridays: It’s Cucumber Season! Sacituzumab Govitecan Demonstrates a Relatively High ORR with Rapid Responses in... ESMO Breast Cancer 2025, Munich, Germany, 14-17 May 2025
